• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Bluebird Bio Inc

+ Add to Watchlist

BLUE:US

40.0100 USD 3.0300 8.19%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Bluebird Bio Inc (BLUE)

Open: 37.0200 Day's Range: 37.0200 - 40.0600 Volume: 526,376
Previous Close: 36.9800 52wk Range: 17.0300 - 41.7500 1-Yr Rtn: +60.68%

Stock Chart for BLUE

No chart data available.
  • BLUE:US 40.0100
  • 1D
  • 1M
  • 1Y
36.9800
Interactive BLUE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BLUE

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.1785
Est. EPS (USD) (12/2014) -1.6470
Est. PEG Ratio -
Market Cap (M USD) 1,144.12
Shares Outstanding (M) 28.60
30 Day Average Volume 333,124
Price/Book (mrq) 6.0531
Price/Sale (ttm) 35.1221
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BLUE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for BLUE

Bluebird Bio, Inc. provides biotechnological products and services. The Company offers gene therapies for severe genetic disorders such as childhood cerebral adrenoleukodystrophy, neurodegenerative disorders, and beta-thalassemia. Bluebird Bio conducts its business in the United States.

Daniel S Lynch "Dan"ChairmanNick LeschlyPresident/CEO
Jeffrey T Walsh "Jeff"COO/TreasurerDavid M DavidsonChief Medical Officer
More Company Profile & Key Executives for BLUE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil